QuidelOrtho Corp (QDEL): Net earnings per share (EPS TTM)
The profit per share trend over the last 12 months reflects the asset's dynamics, where the metric value stands at -5.38. QuidelOrtho (QDEL) management is currently focusing on extracting merger synergies and updating its test portfolio. Revenues are based on the sale of high-cost reagents and seasonal demand. Traditional laboratory tests provide a stable cash flow, supporting the business's operational resilience.
Summary analytical data breakdowns for Quidel Corporation (QDEL)
- current quotes and average value forecast:
- stock exchange capitalization data:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio QuidelOrtho|QDEL - Long-Term Debt to Capital|Short-Term Debt to Capital QuidelOrtho Corp|QDEL - Company Total Debt Obligations|Debts to Book Capitalization QuidelOrtho Corporation|QDEL - Company Long-Term Indebtedness|Company Short-Term Debts QuidelOrtho|Quick Liquidity quidel.com
- earnings and multiples data:
QDEL - Company Net Income|Expected Profit QuidelOrtho|QDEL - Market Cap to Earnings|Future Price to Earnings QuidelOrtho Corporation|QDEL - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio QuidelOrtho Corporation|QDEL - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) QuidelOrtho|QDEL - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months quidel.com|QDEL - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year QuidelOrtho
Fundamental company analysis:QuidelOrtho (QDEL)
Investors are verifying the issuer's financial stability by analyzing its ability to generate real earnings per share. The current level of rolling earnings per share reflects the final annual net income adjusted for capital dilution, which for QuidelOrtho (QDEL) confirms the cost efficiency of complex temperature-controlled reagent logistics and the overall operating margins of the business.
Direct competitors
A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Anbio Biotechnology (NNNN)|soterahealth.com (SHC) - Net earnings per share for the trailing year|OPKO Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) CareDx Corp CDNA|Maravai LifeSciences Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Fulgent FLGT|LAB: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CTKB|OSUR (OraSure) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Exagen Diagnostics XGN|Earnings per share for the last twelve months MDxHealth Inc. (MDXH)|Earnings per share for the last twelve months LUCD (Lucid Diagnostics, Inc)|Earnings per share for the last twelve months Prenetics PRE|Insight Molecular Diagnostics, Inc. (IMDX) - Net earnings per one share for the last twelve months|TRIB - Earnings per share for the last twelve months|Earnings per share for the trailing year PRPH (ProPhase Labs Inc)|AIMD (Ainos Corp) - Net earnings per share for the last 12 months|CODX: Earnings per share for the last four quarters|HSCS (Heart Test Laboratories) - Net earnings per share (EPS TTM)|BMRA: Earnings per share for the trailing year|Earnings per share for the last twelve months Cardio Diagnostics (CDIO)|ONCO - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Virax Biolabs Group Ltd VRAX|Net earnings per share for the trailing year Bluejay Diagnostics Corp|Aspira Women's Health - Net earnings per share (EPS TTM)|AXDX (acceleratediagnostics.com) - Earnings per share for the last 12 months|CNTG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enzo Biochem (ENZ)|Earnings per share for the last twelve months Fresh2 Group Ltd|Earnings per share for the last twelve months GENE|Earnings per share for the last twelve months 23andMe Holding Co. (ME)|Net earnings per share for the last 12 months psychemedics.com PMD
